Form 4 for DNA Ginkgo Bioworks Holdings, Inc.
Accepted 2025-06-13 00:00:00 ET · period of report 2025-06-11 · accession 0001127602-25-017488 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-13 | 2025-06-11 | DNA | SLOAN HARRY | Dir | M - OptEx | — | +10.8K | 271.4K | +4% | — |
| D | 2025-06-13 | 2025-06-12 | DNA | SLOAN HARRY | Dir | A - Grant | $0.00 | +34.4K | 34.4K | New | $0 |
| D | 2025-06-13 | 2025-06-11 | DNA | SLOAN HARRY | Dir | M - OptEx | — | -10.8K | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-06-11 | M | A | 10,822 | — | 271,418 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. |
| 2 | Derivative | Stock Option | 2025-06-12 | A | A | 34,375 | $0.00 | 34,375 | D | $9.29 · — to 2035-06-12 | 34,375 Class A Common Stock | (F3) In accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Program, which became effective on June 12, 2025, the option shall vest and become exercisable in substantially equal installments on each of the first three anniversaries of the date of grant, such that the option shall be fully vested on the third anniversary of the date of grant, subject to the Non-Employee Director continuing in service as a Non-Employee Director through each such vesting date. |
| 3 | Derivative | Restricted Stock Units | 2025-06-11 | M | D | 10,822 | — | 0 | D | $0.00 · — to — | 10,822 Class A Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F2) In accordance with the Issuer's Non-Employee Director Compensation Program, the RSUs granted on June 13, 2024 vested in full in Class A shares on June 11, 2025, which was the day immediately prior to the date of the Issuer's next Annual Meeting of Shareholders occurring after the grant date, and was subject to the Reporting Person continuing in service as a Non-Employee Director of the Issuer through such date. |